Analyze Diet
Journal of the American Veterinary Medical Association2005; 226(10); 1685-1688; doi: 10.2460/javma.2005.226.1685

Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training.

Abstract: To determine whether omeprazole oral paste administered at a dosage of 0.5 or 1 mg/kg (0.23 or 0.45 mg/lb), PO, every 24 hours would effectively prevent the recurrence of gastric ulcers in horses in race training. Methods: Prospective study. Methods: 135 horses. Methods: Horses with gastric ulcers were treated with omeprazole at a dosage of 4 mg/kg (1.8 mg/lb), PO, every 24 hours for 28 days. Horses in the dose selection portion of the study were sham dose treated or received 0.5 or 1 mg of omeprazole/kg, PO, every 24 hours for an additional 28 days. Horses in the dose confirmation portion of the study were sham dose treated or received 1 mg of omeprazole/kg, PO, every 24 hours for an additional 28 days. Gastric ulcers were scored before and after the preventive phase of the study (day 28 to day 56) via gastroscopy, and ulcer scores were compared. Results: Sham-dose-treated horses and horses receiving 0.5 mg of omeprazole/kg had significantly higher ulcer scores than did horses receiving 1 mg of omeprazole/kg. There was a significant difference between the proportion of horses receiving 1 mg of omeprazole/kg (38/48 179%]) that remained ulcer free and the proportion of sham-dose-treated horses (7/44 [16%]) that remained ulcer free. Conclusions: Omeprazole oral paste administered at a dosage of 1 mg/kg, PO, every 24 hours for 28 days was effective for prevention of recurrence of gastric ulcers in horses in race training.
Publication Date: 2005-05-24 PubMed ID: 15906569DOI: 10.2460/javma.2005.226.1685Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Clinical Trial
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on the effectiveness of using omeprazole oral paste to prevent the recurrence of gastric ulcers in racing horses.

Introduction

  • This study aims to ascertain whether administering omeprazole oral paste at specific dosages would prevent gastric ulcers from recurring in training race horses.

Methods

  • The study is prospective in nature and involves 135 horses.
  • Initially, horses with gastric ulcers were given omeprazole at a dosage of 4 mg/kg orally, every 24 hours for a period of 28 days.
  • The research followed two phases: dose selection and dose confirmation. In the dose selection phase, horses were either given a sham dosage or received 0.5 or 1 mg of omeprazole/kg orally, for an additional 28 days.
  • In the dose confirmation phase, horses were either given a sham dosage or received 1 mg of omeprazole/kg orally, for another 28 days.
  • Gastric ulcers in the horses were scored via gastroscopy before and after the preventive phase (day 28 to day 56) and results were compared.

Results

  • The results indicated that horses that received the sham dosage and those given 0.5 mg of omeprazole/kg had significantly higher ulcer scores than those that received 1 mg of omeprazole/kg.
  • There was a considerable difference between the proportion of horses that remained ulcer-free after receiving the 1 mg dosage per kg (38 out of 48, 79%) and those that received the sham dosage (7 out of 44, 16%).

Conclusion

  • The study concluded that omeprazole oral paste, administered at a dosage of 1 mg/kg orally every 24 hours for 28 days, effectively prevents the recurrence of gastric ulcers in horses undergoing race training.

Cite This Article

APA
McClure SR, White GW, Sifferman RL, Bernard W, Hughes FE, Holste JE, Fleishman C, Alva R, Cramer LG. (2005). Efficacy of omeprazole paste for prevention of recurrence of gastric ulcers in horses in race training. J Am Vet Med Assoc, 226(10), 1685-1688. https://doi.org/10.2460/javma.2005.226.1685

Publication

ISSN: 0003-1488
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 226
Issue: 10
Pages: 1685-1688

Researcher Affiliations

McClure, Scott R
  • College of Veterinary Medicine, Iowa State University, Ames, IA 50011-1250, USA.
White, Gary W
    Sifferman, Roger L
      Bernard, William
        Hughes, Faith E
          Holste, John E
            Fleishman, Candis
              Alva, Roberto
                Cramer, Luiz G

                  MeSH Terms

                  • Administration, Oral
                  • Animals
                  • Anti-Ulcer Agents / administration & dosage
                  • Dose-Response Relationship, Drug
                  • Female
                  • Horse Diseases / drug therapy
                  • Horse Diseases / prevention & control
                  • Horses
                  • Male
                  • Ointments
                  • Omeprazole / administration & dosage
                  • Physical Conditioning, Animal / adverse effects
                  • Prospective Studies
                  • Secondary Prevention
                  • Stomach Ulcer / drug therapy
                  • Stomach Ulcer / prevention & control
                  • Stomach Ulcer / veterinary
                  • Treatment Outcome

                  Citations

                  This article has been cited 2 times.
                  1. Wise JC, Raidal SL, Wilkes EJA, Hughes KJ. Intragastric pH of foals admitted to the intensive care unit. J Vet Intern Med 2020 Nov;34(6):2719-2726.
                    doi: 10.1111/jvim.15888pubmed: 32990384google scholar: lookup
                  2. Dogra R, Tyagi SP, Kumar A. Efficacy of Seabuckthorn (Hippophae rhamnoides) Oil vis-a-vis Other Standard Drugs for Management of Gastric Ulceration and Erosions in Dogs. Vet Med Int 2013;2013:176848.
                    doi: 10.1155/2013/176848pubmed: 23853738google scholar: lookup